Serous Maculopathy due to Aspecific Choroidopathy (SMACH): a case report with differential diagnosis based on multimodal imaging analysis.

Doc OphthalmolJun 15, 2026 (epub)
Case ReportOphthalmology

Xuan Ren, Xinxin Yu, Shuai Huang et al.

✦ AI-curated · Sources linked

Case in brief

A 76-year-old Asian female presented with blurred vision in her left eye for six months. Examination revealed multiple yellowish-white subretinal lesions. Multimodal imaging, including OCT and angiography, showed hyperreflective exudates, choroidal thickening, and outer retinal damage. Systemic evaluations ruled out other diseases, leading to a diagnosis of Serous Maculopathy due to Aspecific Choroidopathy (SMACH).

Diagnostic / clinical pearl

Multimodal imaging is essential for diagnosing SMACH, as it reveals characteristic features that can differentiate it from similar conditions like central serous chorioretinopathy and age-related macular degeneration.

Why it matters

Accurate diagnosis of SMACH is critical to avoid mismanagement, particularly in elderly patients where its clinical presentation overlaps with more common chorioretinal diseases.

Source

Published in Doc Ophthalmol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Ophthalmology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.